LAMC2 and hepatocellular carcinoma: Furthermore, knocking down LAMC2 decreased FAK and p65 NF-κB phosphorylation and downregulated ITGB4 in the RRP15-overexpressing HCC cells (Fig. 4C), but did not restore the levels of p-ERK.